Catheter Precision shares surge 13.33% after-hours after securing Hungary's first VIVO system tender, boosting expansion prospects.

Catheter Precision (VTAK) surged 13.33% in after-hours trading following the announcement that its VIVO system secured a multi-year tender at Szeged University Hospital in Hungary. This marks the company’s first installation in the country and a strategic expansion into Central and Eastern Europe, supported by a partnership with local distributor Fototronic. The tender underscores the VIVO system’s growing adoption in premier European hospitals, building on recent multi-year agreements in France. The non-invasive 3D imaging technology, which streamlines ventricular tachycardia ablation procedures, is now positioned for broader market penetration, reinforcing Catheter Precision’s mission to enhance cardiac care globally. The installation, slated for Q1 2026, highlights the company’s progress in establishing its footprint in emerging markets.